<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wu B</submitter><funding>National Institute of Environmental Health Sciences</funding><funding>National Institute of Allergy and Infectious Diseases</funding><funding>National Multiple Sclerosis Society</funding><funding>NIAID NIH HHS</funding><pagination>308-323.e6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7878438</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>54(2)</volume><pubmed_abstract>Th17 cells are known to exert pathogenic and non-pathogenic functions. Although the cytokine transforming growth factor β1 (TGF-β1) is instrumental for Th17 cell differentiation, it is dispensable for generation of pathogenic Th17 cells. Here, we examined the T cell-intrinsic role of Activin-A, a TGF-β superfamily member closely related to TGF-β1, in pathogenic Th17 cell differentiation. Activin-A expression was increased in individuals with relapsing-remitting multiple sclerosis and in mice with experimental autoimmune encephalomyelitis. Stimulation with interleukin-6 and Activin-A induced a molecular program that mirrored that of pathogenic Th17 cells and was inhibited by blocking Activin-A signaling. Genetic disruption of Activin-A and its receptor ALK4 in T cells impaired pathogenic Th</pubmed_abstract><journal>Immunity</journal><pubmed_title>The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.</pubmed_title><pmcid>PMC7878438</pmcid><funding_grant_id>R01 AI123193</funding_grant_id><funding_grant_id>R01 AI131238</funding_grant_id><funding_grant_id>R01 AI160774</funding_grant_id><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Wan YY</pubmed_authors><pubmed_authors>Guo Z</pubmed_authors><pubmed_authors>Markovic-Plese S</pubmed_authors><pubmed_authors>Wu B</pubmed_authors><pubmed_authors>Li P</pubmed_authors><pubmed_authors>Li JL</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Seyedsadr M</pubmed_authors><pubmed_authors>Bi Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation.</name><description>Th17 cells are known to exert pathogenic and non-pathogenic functions. Although the cytokine transforming growth factor β1 (TGF-β1) is instrumental for Th17 cell differentiation, it is dispensable for generation of pathogenic Th17 cells. Here, we examined the T cell-intrinsic role of Activin-A, a TGF-β superfamily member closely related to TGF-β1, in pathogenic Th17 cell differentiation. Activin-A expression was increased in individuals with relapsing-remitting multiple sclerosis and in mice with experimental autoimmune encephalomyelitis. Stimulation with interleukin-6 and Activin-A induced a molecular program that mirrored that of pathogenic Th17 cells and was inhibited by blocking Activin-A signaling. Genetic disruption of Activin-A and its receptor ALK4 in T cells impaired pathogenic Th</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2026-04-14T19:12:28.451Z</modification><creation>2025-04-06T14:57:10.551Z</creation></dates><accession>S-EPMC7878438</accession><cross_references><pubmed>33421362</pubmed><doi>10.1016/j.immuni.2020.12.010</doi></cross_references></HashMap>